|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Toloza EM, Harpole L, Detterbeck F and
McCrory DC: Invasive staging of non-small cell lung cancer: A
review of the current evidence. Chest. 123 (Suppl 1):S157–S166.
2003. View Article : Google Scholar
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer. 96
(Suppl):R40–R44. 2007.PubMed/NCBI
|
|
5
|
Li J, Dong J, Li S, Xia W, Su X, Qin X,
Chen Y, Ding H, Li H, Huang A, et al: An alternative
microRNA-mediated post-transcriptional regulation of GADD45A by p53
in human non-small-cell lung cancer cells. Sci Rep. 7:71532017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ye Y, Zhuang J, Wang G, He S, Ni J, Xia W
and Wang J: microRNA-605 promotes cell proliferation, migration and
invasion in non-small cell lung cancer by directly targeting LATS2.
Exp Ther Med. 14:867–873. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu PL, Liu WL, Chang JM, Chen YH, Liu YP,
Kuo HF, Hsieh CC, Ding YS, Chen WW and Chong IW: MicroRNA-200c
inhibits epithelial-mesenchymal transition, invasion, and migration
of lung cancer by targeting HMGB1. PLoS One. 12:e01808442017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Foroni L, Boehm T, White L, Forster A,
Sherrington P, Liao XB, Brannan CI, Jenkins NA, Copeland NG and
Rabbitts TH: The rhombotin gene family encode related LIM-domain
proteins whose differing expression suggests multiple roles in
mouse development. J Mol Biol. 226:747–761. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dawid IB, Breen JJ and Toyama R: LIM
domains: Multiple roles as adapters and functional modifiers in
protein interactions. Trends Genet. 14:156–162. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aoyama M, Ozaki T, Inuzuka H, Tomotsune D,
Hirato J, Okamoto Y, Tokita H, Ohira M and Nakagawara A: LMO3
interacts with neuronal transcription factor, HEN2, and acts as an
oncogene in neuroblastoma. Cancer Res. 65:4587–4597. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song YF, Hong JF, Liu DL, Lin QA, Lan XP
and Lai GX: miR-630 targets LMO3 to regulate cell growth and
metastasis in lung cancer. Am J Transl Res. 7:1271–1279.
2015.PubMed/NCBI
|
|
12
|
Clark JR, Rumcheva P and Veness MJ:
Analysis and comparison of the 7th edition American Joint Committee
on Cancer (AJCC) nodal staging system for metastatic cutaneous
squamous cell carcinoma of the head and neck. Ann Surg Oncol.
19:4252–4258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma J, Lin Y, Zhan M, Mann DL, Stass SA and
Jiang F: Differential miRNA expressions in peripheral blood
mononuclear cells for diagnosis of lung cancer. Lab Invest.
95:1197–1206. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang Z, Yin J, Fu W, Mo Y, Pan Y, Dai L,
Huang H, Li S and Zhao J: MiRNA 17 family regulates
cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC.
PLoS One. 9:e946392014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Seok JK, Lee SH, Kim MJ and Lee YM:
MicroRNA-382 induced by HIF-1alpha is an angiogenic miR targeting
the tumor suppressor phosphatase and tensin homolog. Nucleic Acids
Res. 42:8062–8072. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ho JY, Hsu RJ, Liu JM, Chen SC, Liao GS,
Gao HW and Yu CP: MicroRNA-382-5p aggravates breast cancer
progression by regulating the RERG/Ras/ERK signaling axis.
Oncotarget. 8:22443–22459. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu M, Jin H, Xu CX, Sun B, Mao Z, Bi WZ
and Wang Y: miR-382 inhibits tumor growth and enhance
chemosensitivity in osteosarcoma. Oncotarget. 5:9472–9483. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen T, Ren H, Thakur A, Yang T, Li Y,
Zhang S, Wang T and Chen M: miR-382 inhibits tumor progression by
targeting SETD8 in non-small cell lung cancer. Biomed Pharmacother.
86:248–253. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu X, Lei Q, Yu Z, Xu G, Tang H, Wang W,
Wang Z, Li G and Wu M: MiR-101 reverses the hypomethylation of the
LMO3 promoter in glioma cells. Oncotarget. 6:7930–7943.
2015.PubMed/NCBI
|
